{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T19:28:21Z","timestamp":1781983701986,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00210-020-01817-1","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T06:02:42Z","timestamp":1579154562000},"page":"1977-1985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bufotalin ameliorates experimental Sj\u00f6gren\u2019s syndrome development by inhibiting Th17 generation"],"prefix":"10.1007","volume":"393","author":[{"given":"Yang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juzhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"1817_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.130.1.203","volume":"130","author":"TC Adamson 3rd","year":"1983","unstructured":"Adamson TC 3rd, Fox RI, Frisman DM, Howell FV (1983) Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 130:203\u2013208","journal-title":"J Immunol"},{"key":"1817_CR2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.autrev.2014.08.022","volume":"13","author":"A Alunno","year":"2014","unstructured":"Alunno A, Carubbi F, Bartoloni E, Bistoni O, Caterbi S, Cipriani P, Giacomelli R, Gerli R (2014) Unmasking the pathogenic role of IL-17 axis in primary Sjogren's syndrome: a new era for therapeutic targeting? Autoimmun Rev 13:1167\u20131173. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.022","journal-title":"Autoimmun Rev"},{"key":"1817_CR3","doi-asserted-by":"publisher","unstructured":"Blokland SLM, Flessa CM, van Roon JAG, Mavragani CP (2019) Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjogren's syndrome. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/key438","DOI":"10.1093\/rheumatology\/key438"},{"key":"1817_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","volume":"179","author":"LA Casciola-Rosen","year":"1994","unstructured":"Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317\u20131330. https:\/\/doi.org\/10.1084\/jem.179.4.1317","journal-title":"J Exp Med"},{"key":"1817_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12935-019-0806-1","volume":"19","author":"CS Cheng","year":"2019","unstructured":"Cheng CS, Wang J, Chen J, Kuo KT, Tang J, Gao H, Chen L, Chen Z, Meng Z (2019) New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin. Cancer Cell Int 19:92. https:\/\/doi.org\/10.1186\/s12935-019-0806-1","journal-title":"Cancer Cell Int"},{"key":"1817_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010) Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 34:400\u2013407. https:\/\/doi.org\/10.1016\/j.jaut.2009.10.004","journal-title":"J Autoimmun"},{"key":"1817_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/ard.2011.154013","volume":"71","author":"F Ciccia","year":"2012","unstructured":"Ciccia F, Guggino G, Rizzo A, Ferrante A, Raimondo S, Giardina A, Dieli F, Campisi G, Alessandro R, Triolo G (2012) Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 71:295\u2013301. https:\/\/doi.org\/10.1136\/ard.2011.154013","journal-title":"Ann Rheum Dis"},{"key":"1817_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/ICU.0000000000000208","volume":"26","author":"CS de Paiva","year":"2015","unstructured":"de Paiva CS, Rocha EM (2015) Sjogren syndrome: what and where are we looking for? Curr Opin Ophthalmol 26:517\u2013525. https:\/\/doi.org\/10.1097\/ICU.0000000000000208","journal-title":"Curr Opin Ophthalmol"},{"key":"1817_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2249.2004.02562.x","volume":"137","author":"P Eriksson","year":"2004","unstructured":"Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T (2004) Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren's syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 137:617\u2013620. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02562.x","journal-title":"Clin Exp Immunol"},{"key":"1817_CR10","first-page":"233","volume":"1","author":"RI Fox","year":"1983","unstructured":"Fox RI, Adamson TC 3rd, Fong S, Young C, Howell FV (1983) Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome. Diagn Immunol 1:233\u2013239","journal-title":"Diagn Immunol"},{"key":"1817_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/art.1780290501","volume":"29","author":"RI Fox","year":"1986","unstructured":"Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV (1986) Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum 29:577\u2013585","journal-title":"Arthritis Rheum"},{"key":"1817_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.4.e14","volume":"89","author":"RM Gowda","year":"2003","unstructured":"Gowda RM, Cohen RA, Khan IA (2003) Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications. Heart 89:e14. https:\/\/doi.org\/10.1136\/heart.89.4.e14","journal-title":"Heart"},{"key":"1817_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.276.5312.604","volume":"276","author":"N Haneji","year":"1997","unstructured":"Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276:604\u2013607","journal-title":"Science"},{"key":"1817_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/eji.201142238","volume":"42","author":"AC Johnson","year":"2012","unstructured":"Johnson AC, Davison LM, Giltiay NV, Vareechon C, Li X, Jorgensen TN (2012) Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease. Eur J Immunol 42:1695\u20131705. https:\/\/doi.org\/10.1002\/eji.201142238","journal-title":"Eur J Immunol"},{"key":"1817_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","volume":"141","author":"R Jonsson","year":"2011","unstructured":"Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S (2011) The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett 141:1\u20139. https:\/\/doi.org\/10.1016\/j.imlet.2011.06.007","journal-title":"Immunol Lett"},{"key":"1817_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/sji.12079","volume":"78","author":"A Karabiyik","year":"2013","unstructured":"Karabiyik A, Peck AB, Nguyen CQ (2013) The important role of T cells and receptor expression in Sjogren's syndrome. Scand J Immunol 78:157\u2013166. https:\/\/doi.org\/10.1111\/sji.12079","journal-title":"Scand J Immunol"},{"key":"1817_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","volume":"175","author":"GE Katsifis","year":"2009","unstructured":"Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 175:1167\u20131177. https:\/\/doi.org\/10.2353\/ajpath.2009.090319","journal-title":"Am J Pathol"},{"key":"1817_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/intimm\/dxr066","volume":"23","author":"X Lin","year":"2011","unstructured":"Lin X, Song JX, Shaw PC, Ng TB, Wong RN, Sze SC, Tong Y, Lee KF, Zhang KY (2011) An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjogren's syndrome. Int Immunol 23:613\u2013624. https:\/\/doi.org\/10.1093\/intimm\/dxr066","journal-title":"Int Immunol"},{"key":"1817_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X et al (2015) Th17 cells play a critical role in the development of experimental Sjogren's syndrome. Ann Rheum Dis 74:1302\u20131310. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204584","journal-title":"Ann Rheum Dis"},{"key":"1817_CR20","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"key":"1817_CR21","first-page":"179","volume":"4","author":"XC Ma","year":"2009","unstructured":"Ma XC, Zhang BJ, Xin XL, Huang SS, Deng S, Zhang HL, Shu XH, Diao YP, Cui J (2009) Simultaneous quantification of seven major bufadienolides in three traditional Chinese medicinal preparations of Chansu by HPLC-DAD. Nat Prod Commun 4:179\u2013184","journal-title":"Nat Prod Commun"},{"key":"1817_CR22","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/ar3207","volume":"12","author":"CQ Nguyen","year":"2010","unstructured":"Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB (2010) Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 12:R220. https:\/\/doi.org\/10.1186\/ar3207","journal-title":"Arthritis Res Ther"},{"key":"1817_CR23","doi-asserted-by":"publisher","unstructured":"Pan Z et al (2019) Bufotalin induces cell cycle arrest and cell apoptosis in human malignant melanoma A375 cells. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2019.7032","DOI":"10.3892\/or.2019.7032"},{"key":"1817_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1573397112666160714164149","volume":"13","author":"P Sandhya","year":"2017","unstructured":"Sandhya P, Kurien BT, Danda D, Scofield RH (2017) Update on pathogenesis of Sjogren's syndrome. Curr Rheumatol Rev 13:5\u201322. https:\/\/doi.org\/10.2174\/1573397112666160714164149","journal-title":"Curr Rheumatol Rev"},{"key":"1817_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","volume":"39","author":"N Singh","year":"2012","unstructured":"Singh N, Cohen PL (2012) The T cell in Sjogren's syndrome: force majeure, not spectateur. J Autoimmun 39:229\u2013233. https:\/\/doi.org\/10.1016\/j.jaut.2012.05.019","journal-title":"J Autoimmun"},{"key":"1817_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/14397595.2014.951144","volume":"25","author":"H Tsuboi","year":"2015","unstructured":"Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T (2015) Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjogren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-interim analysis of 32 patients for 24 weeks. Mod Rheumatol 25:187\u2013193. https:\/\/doi.org\/10.3109\/14397595.2014.951144","journal-title":"Mod Rheumatol"},{"key":"1817_CR27","doi-asserted-by":"publisher","unstructured":"Verstappen GM, Kroese FGM, Bootsma H (2019) T cells in primary Sjogren's syndrome: targets for early intervention. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kez004","DOI":"10.1093\/rheumatology\/kez004"},{"key":"1817_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","volume":"182","author":"FB Vivino","year":"2017","unstructured":"Vivino FB (2017) Sjogren's syndrome: clinical aspects. Clin Immunol 182:48\u201354. https:\/\/doi.org\/10.1016\/j.clim.2017.04.005","journal-title":"Clin Immunol"},{"key":"1817_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3892\/ijo.2011.1182","volume":"40","author":"P Waiwut","year":"2012","unstructured":"Waiwut P, Inujima A, Inoue H, Saiki I, Sakurai H (2012) Bufotalin sensitizes death receptor-induced apoptosis via bid- and STAT1-dependent pathways. Int J Oncol 40:203\u2013208. https:\/\/doi.org\/10.3892\/ijo.2011.1182","journal-title":"Int J Oncol"},{"key":"1817_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jep.2019.03.042","volume":"237","author":"WL Wei","year":"2019","unstructured":"Wei WL, Hou JJ, Wang X, Yu Y, Li HJ, Li ZW, Feng ZJ, Qu H, Wu WY, Guo DA (2019) Venenum bufonis: an overview of its traditional use, natural product chemistry, pharmacology, pharmacokinetics and toxicology. J Ethnopharmacol 237:215\u2013235. https:\/\/doi.org\/10.1016\/j.jep.2019.03.042","journal-title":"J Ethnopharmacol"},{"key":"1817_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/cmi.2017.8","volume":"14","author":"F Xiao","year":"2017","unstructured":"Xiao F, Lin X, Tian J, Wang X, Chen Q, Rui K, Ma J, Wang S, Wang Q, Wang X, Liu D, Sun L, Lu L (2017) Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjogren's syndrome. Cell Mol Immunol 14:924\u2013934. https:\/\/doi.org\/10.1038\/cmi.2017.8","journal-title":"Cell Mol Immunol"},{"key":"1817_CR32","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.4049\/jimmunol.0902551","volume":"184","author":"M Yang","year":"2010","unstructured":"Yang M et al (2010) Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184:3321\u20133325. https:\/\/doi.org\/10.4049\/jimmunol.0902551","journal-title":"J Immunol"},{"key":"1817_CR33","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ajpath.2012.03.010","volume":"180","author":"M Yang","year":"2012","unstructured":"Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau CS, Cao X, Lu L (2012) IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol 180:2375\u20132385. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.010","journal-title":"Am J Pathol"},{"key":"1817_CR34","doi-asserted-by":"publisher","first-page":"606195","DOI":"10.1155\/2012\/606195","volume":"2012","author":"R Yoshimi","year":"2012","unstructured":"Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y (2012) Clinical and pathological roles of Ro\/SSA autoantibody system. Clin Dev Immunol 2012:606195. https:\/\/doi.org\/10.1155\/2012\/606195","journal-title":"Clin Dev Immunol"},{"key":"1817_CR35","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1172\/JCI123801","volume":"129","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu RB, Cao Q, Fan KQ, Huang LJ, Yu JS, Gao ZJ, Huang T, Zhong JY, Mao XT, Wang F, Xiao P, Zhao Y, Feng XH, Li YY, Jin J (2019) USP16-mediated deubiquitination of calcineurin a controls peripheral T cell maintenance. J Clin Invest 129:2856\u20132871. https:\/\/doi.org\/10.1172\/JCI123801","journal-title":"J Clin Invest"},{"key":"1817_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbrc.2014.07.077","volume":"451","author":"YR Zhu","year":"2014","unstructured":"Zhu YR, Xu Y, Fang JF, Zhou F, Deng XW, Zhang YQ (2014) Bufotalin-induced apoptosis in osteoblastoma cells is associated with endoplasmic reticulum stress activation. Biochem Biophys Res Commun 451:112\u2013118. https:\/\/doi.org\/10.1016\/j.bbrc.2014.07.077","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-020-01817-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:17:10Z","timestamp":1695619030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-020-01817-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01817-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}